| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |